These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 33832645)

  • 1. Efficacy and safety of a new vaginal gel for the treatment of symptoms associated with vulvovaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled study.
    De Seta F; Caruso S; Di Lorenzo G; Romano F; Mirandola M; Nappi RE
    Maturitas; 2021 May; 147():34-40. PubMed ID: 33832645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom.
    Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH
    J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom.
    Kroll R; Archer DF; Lin Y; Sniukiene V; Liu JH
    Menopause; 2018 Feb; 25(2):133-138. PubMed ID: 28926514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal ChangEs) survey.
    Kingsberg SA; Wysocki S; Magnus L; Krychman ML
    J Sex Med; 2013 Jul; 10(7):1790-9. PubMed ID: 23679050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-Term Efficacy and Safety of Non-Ablative Laser Treatment Alone or with Estriol or Moisturizers in Postmenopausal Women with Vulvovaginal Atrophy.
    Alvisi S; Lami A; Baldassarre M; Lenzi J; Mancini I; Seracchioli R; Meriggiola MC
    J Sex Med; 2022 May; 19(5):761-770. PubMed ID: 35370104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TX-004HR Improves Sexual Function as Measured by the Female Sexual Function Index in Postmenopausal Women With Vulvar and Vaginal Atrophy: The REJOICE Trial.
    Kingsberg SA; Derogatis L; Simon JA; Constantine GD; Graham S; Bernick B; Gasper G; Mirkin S
    J Sex Med; 2016 Dec; 13(12):1930-1937. PubMed ID: 27692842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravaginal Testosterone Improves Sexual Satisfaction and Vaginal Symptoms Associated With Aromatase Inhibitors.
    Davis SR; Robinson PJ; Jane F; White S; White M; Bell RJ
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4146-4154. PubMed ID: 30239842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the Benefits of CO
    Jankovic S; Rovcanin M; Tomic A; Jurisic A; Milovanovic Z; Zamurovic M
    Medicina (Kaunas); 2024 Jun; 60(7):. PubMed ID: 39064488
    [No Abstract]   [Full Text] [Related]  

  • 9. Visual improvements in vaginal mucosa correlate with symptoms of VVA: data from a double-blind, placebo-controlled trial.
    Simon JA; Archer DF; Kagan R; Bernick B; Graham S; Constantine GD; Mirkin S
    Menopause; 2017 Sep; 24(9):1003-1010. PubMed ID: 28419068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TX-004HR clinically improves symptoms of vulvar and vaginal atrophy in postmenopausal women.
    Simon JA; Kagan R; Archer DF; Constantine GD; Bernick B; Graham S; Mirkin S
    Climacteric; 2019 Aug; 22(4):412-418. PubMed ID: 30862193
    [No Abstract]   [Full Text] [Related]  

  • 11. Polycarbophil vaginal moisturizing gel versus hyaluronic acid gel in women affected by vaginal dryness in late menopausal transition: A prospective randomized trial.
    Cagnacci A; Barattini DF; Casolati E; Pecoroni A; Mangrella M; Patrascu LC
    Eur J Obstet Gynecol Reprod Biol; 2022 Mar; 270():239-245. PubMed ID: 35131532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of intravaginal dehydroepiandrosterone (DHEA) on moderate to severe dyspareunia and vaginal dryness, symptoms of vulvovaginal atrophy, and of the genitourinary syndrome of menopause.
    Labrie F; Archer DF; Koltun W; Vachon A; Young D; Frenette L; Portman D; Montesino M; Côté I; Parent J; Lavoie L; Beauregard A; Martel C; Vaillancourt M; Balser J; Moyneur É;
    Menopause; 2016 Mar; 23(3):243-56. PubMed ID: 26731686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local ultra-low-dose estriol gel treatment of vulvo-vaginal atrophy: efficacy and safety of long-term treatment.
    Villa P; Tagliaferri V; Amar ID; Cipolla C; Ingravalle F; Scambia G; Ricciardi W; Lanzone A
    Gynecol Endocrinol; 2020 Jun; 36(6):535-539. PubMed ID: 31847628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of hyaluronate-based pessaries in the treatment of vulvovaginal atrophy in postmenopausal women.
    Nappi RE; Kotek M; Brešt'anský A; Giordan N; Tramentozzi E
    Climacteric; 2020 Oct; 23(5):519-524. PubMed ID: 32396754
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial.
    Archer DF; Goldstein SR; Simon JA; Waldbaum AS; Sussman SA; Altomare C; Zhu J; Yoshida Y; Schaffer S; Soulban G
    Menopause; 2019 Jan; 26(6):611-621. PubMed ID: 30694917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic floor muscles training to reduce symptoms and signs of vulvovaginal atrophy: a case study.
    Mercier J; Morin M; Lemieux MC; Reichetzer B; Khalifé S; Dumoulin C
    Menopause; 2016 Jul; 23(7):816-20. PubMed ID: 27219835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ospemifene, a non-oestrogen selective oestrogen receptor modulator for the treatment of vaginal dryness associated with postmenopausal vulvar and vaginal atrophy: a randomised, placebo-controlled, phase III trial.
    Portman D; Palacios S; Nappi RE; Mueck AO
    Maturitas; 2014 Jun; 78(2):91-8. PubMed ID: 24679891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, placebo-controlled trial.
    Constantine G; Graham S; Portman DJ; Rosen RC; Kingsberg SA
    Climacteric; 2015 Apr; 18(2):226-32. PubMed ID: 25252699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estradiol softgel inserts for the treatment of VVA symptoms: an expert opinion.
    Liu JH; Bernick B; Mirkin S
    Expert Opin Drug Deliv; 2020 Nov; 17(11):1573-1581. PubMed ID: 32877254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of non-hormonal remedies for vaginal dryness: open, prospective, randomized trial.
    Stute P; May TW; Masur C; Schmidts-Winkler IM
    Climacteric; 2015; 18(4):582-9. PubMed ID: 25845406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.